TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.

Yong-Chen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.